Kingswood Capital Partners Completes $8 Million IPO for WORK Medical Technology Group
New York, Kingswood Capital Partners, LLC has announced the successful closing of an initial public offering (IPO) for 2,000,000 ordinary shares at a public offering price of US$4.00 per share for its client, WORK Medical Technology Group LTD. (Nasdaq: WOK), a prominent supplier of medical devices. The shares have started trading under the ticker symbol "WOK."
Gross Proceeds from the Offering
The IPO generated approximately US$8.00 million in gross proceeds, which will support the Company's various growth initiatives.
Utilization of Offering Proceeds
The funds raised from the IPO are designated for essential improvements, including upgrading production equipment, expanding production capacity, developing new medical consumables, implementing effective marketing strategies, acquiring patents, and covering general working capital needs. This financial infusion will significantly enhance WORK Medical Technology Group's operational capabilities.
Key Players in the Offering
The Offering was executed on a firm commitment basis, with Kingswood Capital Partners, LLC serving as the sole book-running manager. Hunter Taubman Fischer & Li LLC acted as U.S. legal counsel for the Company, while Ortoli Rosenstadt LLP provided legal support for Kingswood during the Offering.
Regulatory Framework for the Offering
A registration statement on Form F-1 concerning the Offering has been filed with the U.S. Securities and Exchange Commission (SEC) and was recently declared effective. The materials related to the Offering were distributed exclusively through a prospectus that is part of this registration statement, ensuring adherence to regulatory requirements.
Acquisition of the Final Prospectus
Individuals or entities interested in obtaining the final prospectus for the Offering can do so directly from Kingswood. Company representatives are available for inquiries via telephone or email.
Company Overview of WORK Medical Technology Group
WORK Medical Technology Group LTD is a key player in the medical device industry, focusing on the development and manufacturing of Class I and II medical devices. Their extensive portfolio includes over 21 products, featuring innovative multifunctional masks and various medical consumables designed to address a wide array of healthcare needs.
Quality and Compliance
All products from WORK Medical Technology have been successfully marketed across 34 provincial-level regions. Additionally, many products have received approval and registration from the U.S. Food and Drug Administration, enabling their entry into the U.S. market. This compliance highlights their dedication to quality and adherence to regulatory standards.
About Kingswood Capital Partners
Kingswood, part of the Kingswood Group, operates as a network of wealth management firms that support independent financial advisors. With over $14 billion in assets under management and backing for 400 registered individuals, Kingswood combines extensive resources with a personalized service approach.
Contact Information
The media can contact Kingswood Capital Partners through Ryan Sabet, the Director of Acquisition, Recruitment & Strategic Initiatives. His direct line is available for inquiries, providing a channel for media engagement.
Frequently Asked Questions
What is the purpose of the recent IPO announced by Kingswood?
The IPO is designed to raise funds for WORK Medical Technology Group to improve their production capabilities and expand their range of products.
How many shares were offered in the IPO?
A total of 2,000,000 ordinary shares were offered at a price of US$4.00 each.
What will the proceeds from the IPO be used for?
The proceeds will be utilized for upgrading production equipment, developing new medical devices, marketing initiatives, patent acquisitions, and general corporate purposes.
What is the significance of the ticker symbol 'WOK'?
The ticker symbol 'WOK' represents WORK Medical Technology Group, which is now publicly traded following the successful IPO.
Who were the legal representatives for the Offering?
Hunter Taubman Fischer & Li LLC served as U.S. legal counsel for WORK Medical Technology Group, while Ortoli Rosenstadt LLP provided legal counsel for Kingswood during the Offering.
